Cardiovascular Diseases

Medizentrum Essen Borbeck is conducting studies that aim to improve outcomes for patients with cardiovascular disease, focusing on conditions such as atherosclerosis, elevated lipoprotein(a), and hypertension. The trials evaluate novel lipid‑lowering agents and blood‑pressure medicines to lower the risk of major cardiac events.

  • Atherosclerotic cardiovascular disease
  • Elevated lipoprotein(a)
  • Hypertension
  • Resistant hypertension
  • Heart failure with preserved ejection fraction
  • Major adverse cardiovascular events

A total of 38 trials are active at the site, supported by five investigators, making it a key centre for cardiovascular research in the region.

Digestive System Diseases

The centre is exploring new therapeutic options for digestive system disorders, including functional bowel conditions and acute infections. Research aims to relieve symptoms and improve quality of life for patients with irritable bowel syndrome and acute bronchitis‑related cough.

  • Irritable bowel syndrome (diarrhoea‑predominant)
  • Acute bronchitis
  • Acute pharyngitis
  • Chronic bronchitis

Across the 38 ongoing trials, five investigators contribute to advancing digestive health at this hospital.

Hormonal Diseases

Studies at the site target hormonal and metabolic disorders such as type 2 diabetes and obesity, assessing both weight‑loss strategies and glucose‑control therapies. The goal is to determine safe and effective approaches for long‑term metabolic health.

  • Type 2 diabetes
  • Obesity
  • Overweight without diabetes
  • Hypercholesterolemia
  • Metabolic syndrome

With 38 clinical studies underway and a dedicated team of five investigators, the hospital serves as a hub for hormonal disease research in Europe.

Immune System Diseases

The facility is evaluating preventive and therapeutic solutions for immune‑mediated infections, including vaccines against respiratory syncytial virus, influenza, and herpes zoster. These trials measure immune response durability and protection rates in older adults.

  • Respiratory syncytial virus (RSV) infection
  • Influenza
  • Herpes zoster
  • Human metapneumovirus

A total of 38 trials and five investigators focus on strengthening immunity and reducing infection‑related morbidity at Medizentrum Essen Borbeck.

Nervous System Diseases

Research efforts are directed toward improving brain health in patients with post‑COVID cognitive impairment. The studies test natural extracts and other interventions to enhance memory and attention after viral infection.

  • Cognitive impairment associated with post‑COVID‑19 syndrome
  • Neurocognitive decline

The site’s portfolio of 38 trials, overseen by five investigators, includes dedicated neuroscience investigations.

Nutritional and Metabolic Diseases

Clinical work at the centre addresses nutritional and metabolic conditions such as obesity, overweight, and related metabolic risk factors. Trials evaluate novel agents for weight reduction and metabolic regulation.

  • Obesity
  • Overweight
  • Type 2 diabetes
  • Metabolic syndrome
  • Elevated lipoprotein(a)

With 38 active studies and a team of five investigators, the hospital is a regional leader in metabolic disease research.

Otorhinolaryngologic Diseases

The institution conducts trials aimed at relieving symptoms of allergic rhinitis and related ENT conditions. Immunotherapy and symptom‑relief lozenges are among the interventions being tested.

  • Seasonal allergic rhinitis
  • Rhinoconjunctivitis induced by house dust mite
  • Acute pharyngitis
  • Allergic rhinitis with or without asthma

A total of 38 clinical trials, supported by five investigators, focus on improving upper‑airway health at this site.

Respiratory Tract Diseases

Ongoing investigations target respiratory illnesses such as chronic obstructive pulmonary disease, acute bronchitis, and viral lower‑respiratory infections. The aim is to reduce exacerbations and improve lung function.

  • Chronic obstructive pulmonary disease (COPD)
  • Acute bronchitis
  • Chronic bronchitis
  • Respiratory syncytial virus lower‑respiratory disease
  • Human metapneumovirus infection

The site supports 38 trials with five investigators, positioning it as a key centre for respiratory research in Germany.

Virus Diseases

The hospital is actively testing vaccines and antiviral strategies for viral diseases, especially those affecting older adults. Studies measure vaccine efficacy, safety, and long‑term immune protection.

  • Respiratory syncytial virus (RSV)
  • Influenza A and B
  • Human metapneumovirus
  • Herpes zoster virus

With 38 trials underway and a team of five investigators, Medizentrum Essen Borbeck contributes significantly to viral disease prevention research.

Immune System Phenomena

Research programs examine immune response mechanisms to assess how new vaccines stimulate humoral immunity and how immunotherapies modulate disease activity. The focus is on durability of protection and safety profiles.

  • Humoral immune response to RSV vaccine
  • Immunogenicity of influenza vaccine
  • Immune modulation in allergic rhinitis
  • Safety of immune‑targeted therapies

The centre’s portfolio of 38 active trials, guided by five investigators, underlines its commitment to advancing immunology research.